The US Food and Drug Administration will start using a risk-based
approach for prioritising site inspections for certain
pharmaceutical products, the agency has announced in a final report
on its current good manufacturing practice...
The US Food and Drug Administration is planning to hold a meeting
in June to re-examine its regulations on electronic records and
signatures, used to generate the audit trail in the food and drug
industries, to examine whether some...